Azithromycin for sarcoidosis cough: an open-label exploratory clinical trial.

In our sarcoidosis trial cohort, subjects with baseline cough severity VAS≥40 mm had significantly more coughs in 24 h and a trend towards larger reduction in cough counts in response to treatment, although the latter did not reach statistical significance (p=0.057).

also in 111,027 other papers